Originally published byEU-Startups
CriteriaCaixa, the Barcelona-based holding company that manages the business assets of ‘la Caixa’ Banking Foundation, today announces a reboot of its startup investment business to facilitate the growth of science and technology-based high-potential emerging companies. Through its two funds, Criteria Bio Ventures and Criteria Venture Tech, it plans to invest €300 million ($343 million) in […]
The post €300 million for Iberian BioTech and DeepTech as CriteriaCaixa rebrands its VC arm appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
ORiS secures €5 million to develop wireless power transmission systems for space and dual-use applications
7h ago
Burnham sparks backlash over reported plans to ditch DSIT
1d ago
'If you're not AI-native, you're not getting funded': European fintech's H1 funding figures
2h ago
Viking 1 landed on Mars 50 years ago
3h ago
15 anti-fraud startups to watch in 2026, according to investors
1d ago